Mr Mark Cadman

ebilities, the trading name of Lewis Cadman Consulting, is an Australian technology company who have designed, researched and developed an innovative range of online mental agility tests. These world leading tests are designed for use anywhere in the world to identify high potential candidates with the learning agility and problem solving skills needed for success in 21st century workplaces, and the confidence in their abilities to make timely decisions without the 'derailing' influence of overconfidence or underconfidence.

ebilities have constructed their short, sharp tests from the ground up for use in both established and emerging markets, for both small scale and mass recruitment. They are available in a number of languages, and can be taken on computers, tablets or mobile devices.

ebilities
Director 
Your interests

Our research interests surround the role of both mental agility and cognitive confidence in effective decision making.

Under conditions of uncertainty, a person’s mental agility is important because it underpins the formation of quick and accurate judgments, leading to better decision-making. But cognitive confidence is what turns ability into action. As a person’s cognitive confidence increases so does the likelihood that they will act decisively on their judgments. That’s good when people have the ability to back it up, and not so good when they don’t!

In employment settings, the most common finding in our research to date is that a lot of people tend to over-estimate their abilities. The upshot of this is that many people are overconfident and may systematically make sub-optimal decisions because they act on biased beliefs about their true abilities. Our research has also identified groups of higher ability people who tend to under-estimate their abilities, and who may be affected by the "Imposter Syndrome".

We have also undertaken studies under a TechVouchers grant into the interaction of mental agility and cognitive confidence in academic achievement of primary school children. The academic team we partnered with at the University of Newcastle here in NSW, have now had three papers published on the results of the research.

Dr Albert Canagasabey

Deloitte
Director | Global Investment and Innovation Incentives 
Your interests

I provide advice and assistance to companies in relation to government incentives available (R&D Tax Incentive and grants). My extensive scientific educational background and research (conducted at universities and CRCs) experience equips me with the necessary capability to provide sound advice in relation to the eligibility of R&D activities to the R&D Tax Incentive as well as grants.

Would appreciate an opportunity to meet CRC representatives to explore the possibility of partnering with them to assist their industry partners.

I am also open to meeting with companies to provide advice on government incentives that may be available to them.

Mr Jace Carson

The University of Canterbury (UC) continues to undertake world-ranked research that is relevant, and has impact within national and international arenas. A key aspect of our continued research success is collaboration and partnership. Collaboration (with other researchers, business, or community groups) has enabled the university to ‘punch above its weight’, whilst retaining its intellectual rigour, desire to tackle important research questions, and desire to a make a difference by creating and disseminating new knowledge.

University of Canterbury
LinkedIn logo Research Consultant 
Your interests

Interested in partnering in other CRCs particularly where the outcomes will have Australasian benefits or where our particular capabilities are complementary. Also open to new links with industry and government sector.

 

Mr Brett Carter

Cancer Therapeutics CRC (CTx) is in the business of finding cures for cancer. It was founded in 2007 and received an initial seven years of funding from the Cooperative Research Centre (CRC) Programme. It is a collaborative partnership of leading research institutes, universities and commercial enterprises that translates Australia’s innovative research discoveries into new cancer drugs ready for clinical development. 

CTx CRC Ltd
Chief Operating Officer 
Your interests
Biotechnology

Mrs Natalie Chapman

gemaker
Managing Director 
Your interests

My passion is helping innovators commercialise their new ideas and help researchers better engage with industry.

I have more than 16 years of marketing and commercialisation experience in STEM related technologies and I've worked with numerous CRCs, research organisations and companies to provide measurable impact. I'd enjoy meeting senior management from CRCs, research organisations and innovative companies to discuss what they need help with in getting their innovations to market or identifying innovations.

Mr Ian Christensen

iMOVE Australia
Managing Director 
Your interests

Primary interest is in transport and mobility and anything that might improve the movement of people or goods.

Also very interested in protocols for data sharing

Mr David Chuter

Innovative Manufacturing CRC
CEO and Managing Director 
Your interests
We would like to meet people from industry, manufacturing businesses in particular, and the research community who are interested in research in innovative manufacturing technologies and processes.

Prof Simon Clark

Macquarie University
dHOD Dept. of Earth and Planetary Sciences 
Your interests

Cement
Concrete
Infrastructure
Sensing
Photonics

Dr Linda Colley

CQUniversity
Senior Lecturer/DL - HRM 
Your interests
Dr Linda Colley is Discipline Leader and Senior Lecturer in Human Resource Management and Industrial Relations at CQUniversity. Her research focuses on public management and public employment themes including merit, tenure, age and gender. Her current projects include an ARC Discovery funded project on Senior Executives in Australian public services, an ANZSOG funded project on the role of middle managers in progressing gender equity, and a CQU funded project on women and superannuation.

Prof Ian Cooke

CRC for Mental Health
CEO 
Your interests

The CRC for Mental Health is developing objective biomarker-based tools (diagnostics, screening tests etc) to support clinical decisions in mental health practice, with a particular focus on Alzheimer's disease, Parkinson's disease and schizophrenia.

We are interested in meeting with diagnostics companies that wish to acquire new technologies and companies that wish to use such tools to facilitate clinical development programs for new therapies.